Hostname: page-component-89b8bd64d-nlwjb Total loading time: 0 Render date: 2026-05-09T04:17:32.680Z Has data issue: false hasContentIssue false

The anomalous effect of COVID-19 pandemic restrictions on the duration of untreated psychosis

Published online by Cambridge University Press:  04 December 2024

Jessica Nicholls-Mindlin
Affiliation:
Medical Sciences Division, University of Oxford, Oxford, UK; and Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
Hadar Hazan
Affiliation:
Program for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA
Bin Zhou
Affiliation:
Yale Centre for Analytical Sciences (YCAS), Yale School of Public Health, New Haven, Connecticut, USA
Fangyong Li
Affiliation:
Yale Centre for Analytical Sciences (YCAS), Yale School of Public Health, New Haven, Connecticut, USA
Maria Ferrara
Affiliation:
Program for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA; and Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrrara, Ferrara, Italy
Nina Levine
Affiliation:
Program for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA
Sarah Riley
Affiliation:
Program for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA
Sneha Karmani
Affiliation:
Program for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA
Walter S. Mathis
Affiliation:
Program for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA
Matcheri S. Keshavan
Affiliation:
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Vinod H. Srihari*
Affiliation:
Program for Specialized Treatment Early in Psychosis (STEP), Yale University School of Medicine, New Haven, Connecticut, USA
*
Correspondence: Vinod H. Srihari. Email: vinod.srihari@yale.edu
Rights & Permissions [Opens in a new window]

Abstract

We investigated the impact of COVID-19 restrictions on the duration of untreated psychosis (DUP). First-episode psychosis admissions (n = 101) to the STEP Clinic in Connecticut showed DUP reduction (P = 0.0015) during the pandemic, with the median reducing from 208 days pre-pandemic to 56 days in the early pandemic period, and subsequently increasing to 154 days (P = 0.0281). Time from psychosis onset to antipsychotic prescription decreased significantly in the pandemic (P = 0.0183), with the median falling from 117 to 35 days. This cohort study demonstrates an association between greater pandemic restrictions and marked DUP reduction, and provides insights for future early detection efforts.

Information

Type
Short report
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
Copyright © Yale University, 2024. Published by Cambridge University Press on behalf of Royal College of Psychiatrists
Figure 0

Fig. 1 Box and whisker plots of DUP-Total, DUP-Demand and DUP-Supply in the pre, early and late pandemic epochs. Box and whisker plots of log (DUP) in the pre-, early and late pandemic epochs for (a) DUP-Total (b) DUP-Demand and (c) DUP-Supply. The green line represents the log (median), the box represents the log (25th and 75th) percentiles, the whiskers represent the maximum and minimum below the upper and lower fence, and the red diamond represents the log (mean). The results of pairwise comparisons of pre-and early pandemic, and of early and late pandemic, are reported. DUP, duration of untreated psychosis; DUP-Demand, time in days between psychosis onset and first antipsychotic use; DUP-Supply, time in days between first antipsychotic use and enrolment into the programme; DUP-Total, time in days between psychosis onset and enrolment into the programme.

Supplementary material: File

Nicholls-Mindlin et al. supplementary material

Nicholls-Mindlin et al. supplementary material
Download Nicholls-Mindlin et al. supplementary material(File)
File 22.9 KB
Submit a response

eLetters

No eLetters have been published for this article.